MicroRNA analysis of childhood atopic dermatitis reveals a role for miR‐451a*

Abstract

In infants with AD, a distinct peripheral blood miRNA signature is seen, highlighting the systemic effects of the disease. miR-451a is uniquely expressed in different blood compartments of patients with AD and may serve as a promising novel biomarker for the early diagnosis of AD.